{"id":"https://openalex.org/W7224769764","doi":"https://doi.org/10.5281/zenodo.23804936","title":"A REVIEW ON METHOD DEVELOPMENT AND VALIDATION OF SELECTED ANTI HYPERTENSIVE DRUG TIRZEPATIDE BY USING DIFFERENT ANALYTICAL TECHNIQUES","display_name":"A REVIEW ON METHOD DEVELOPMENT AND VALIDATION OF SELECTED ANTI HYPERTENSIVE DRUG TIRZEPATIDE BY USING DIFFERENT ANALYTICAL TECHNIQUES","publication_year":2026,"publication_date":"2026-11-01","ids":{"openalex":"https://openalex.org/W7224769764","doi":"https://doi.org/10.5281/zenodo.23804936"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23804936","doi":"https://doi.org/10.5281/zenodo.23804936","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804936","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"volume":null,"type":"article","indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23804936","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160158973","display_name":"Dr. Santhosh Illendula*1, Mothe Praneeth2, Vusala Tejaswi2, Varipally Sai Sindhu2, Vootkuri Nihathi2, Jetamoni Mahesh2, Kurumeti Divya2, Dr. Suthakaran Raj3","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Dr. Santhosh Illendula*1, Mothe Praneeth2, Vusala Tejaswi2, Varipally Sai Sindhu2, Vootkuri Nihathi2, Jetamoni Mahesh2, Kurumeti Divya2, Dr. Suthakaran Raj3","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5160158973"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.79965422,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tirzepatide","display_name":"tirzepatide","score":1.0},{"id":"https://openalex.org/keywords/analytical-method-development","display_name":"analytical method development","score":0.847000002861023},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.8130000233650208},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8999999761581421},{"id":"https://openalex.org/keywords/obesity","display_name":"obesity","score":0.972000002861023},{"id":"https://openalex.org/keywords/pharmaceutical-quality-control","display_name":"pharmaceutical quality control","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.6570000052452087},{"id":"https://openalex.org/keywords/uv-vis-spectroscopy","display_name":"UV-Vis spectroscopy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/high-performance-liquid-chromatography","display_name":"HPLC","score":0.9150000214576721},{"id":"https://openalex.org/keywords/hptlc","display_name":"HPTLC","score":0.8130000233650208},{"id":"https://openalex.org/keywords/lc-ms","display_name":"LC-MS","score":0.890999972820282},{"id":"https://openalex.org/keywords/purity-determination","display_name":"purity determination","score":0.3779999911785126}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5565000176429749},{"id":"https://openalex.org/C3020479747","wikidata":"https://www.wikidata.org/wiki/Q1029907","display_name":"Gastric emptying","level":3,"score":0.5098000168800354},{"id":"https://openalex.org/C43214815","wikidata":"https://www.wikidata.org/wiki/Q7310987","display_name":"Reliability (semiconductor)","level":3,"score":0.49950000643730164},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.43810001015663147},{"id":"https://openalex.org/C151201525","wikidata":"https://www.wikidata.org/wiki/Q177239","display_name":"Limit (mathematics)","level":2,"score":0.4133000075817108},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.40299999713897705},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3953000009059906},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.39329999685287476},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.3650999963283539},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.3346000015735626},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.32749998569488525},{"id":"https://openalex.org/C2776436953","wikidata":"https://www.wikidata.org/wiki/Q5163215","display_name":"Consistency (knowledge bases)","level":2,"score":0.31940001249313354},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.31859999895095825},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.295199990272522},{"id":"https://openalex.org/C106186310","wikidata":"https://www.wikidata.org/wiki/Q1437823","display_name":"Pharmaceutical formulation","level":2,"score":0.28850001096725464},{"id":"https://openalex.org/C183696295","wikidata":"https://www.wikidata.org/wiki/Q2487696","display_name":"Biochemical engineering","level":1,"score":0.2833000123500824},{"id":"https://openalex.org/C204320433","wikidata":"https://www.wikidata.org/wiki/Q7268772","display_name":"Quality by Design","level":3,"score":0.27959999442100525},{"id":"https://openalex.org/C2779555806","wikidata":"https://www.wikidata.org/wiki/Q3108899","display_name":"Glipizide","level":3,"score":0.2711000144481659},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.2694000005722046},{"id":"https://openalex.org/C2780980858","wikidata":"https://www.wikidata.org/wiki/Q110022","display_name":"Dual (grammatical number)","level":2,"score":0.26739999651908875},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.2574999928474426}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23804936","doi":"https://doi.org/10.5281/zenodo.23804936","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804936","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.5281/zenodo.23804937","doi":"https://doi.org/10.5281/zenodo.23804937","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804937","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23804936","doi":"https://doi.org/10.5281/zenodo.23804936","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23804936","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.504800021648407,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7155869499","https://openalex.org/W7204647889","https://openalex.org/W4415071799","https://openalex.org/W7124447065","https://openalex.org/W7081909197","https://openalex.org/W7163380106","https://openalex.org/W7138907367","https://openalex.org/W7163592285","https://openalex.org/W7128075160","https://openalex.org/W4415556720"],"abstract_inverted_index":{"Tirzepatide":[0,44],"is":[1,63,102],"a":[2],"novel":[3],"dual":[4],"glucose-dependent":[5,37],"insulinotropic":[6],"polypeptide":[7],"(GIP)":[8],"and":[9,25,33,40,49,57,72,90,108,128,145,150,166],"glucagon-like":[10],"peptide-1":[11],"(GLP-1)":[12],"receptor":[13],"agonist":[14],"used":[15],"primarily":[16],"for":[17,65,97,140,162],"the":[18,29,66,106,111,141,156],"management":[19],"of":[20,31,75,110,126,130,143,158,169],"type":[21],"2":[22],"diabetes":[23],"mellitus":[24],"obesity.":[26],"It":[27],"mimics":[28],"actions":[30],"GIP":[32],"GLP-1,":[34],"thereby":[35],"enhancing":[36],"insulin":[38],"secretion":[39],"reducing":[41],"glucagon":[42],"secretion.":[43],"also":[45,154],"delays":[46],"gastric":[47],"emptying":[48],"promotes":[50],"satiety,":[51],"contributing":[52],"to":[53,104],"improved":[54],"glycemic":[55],"control":[56,74,165],"body-weight":[58],"reduction.":[59],"Analytical":[60],"method":[61],"development":[62],"essential":[64],"accurate":[67],"identification,":[68],"quantification,":[69],"purity":[70],"assessment,":[71],"quality":[73,164],"tirzepatide":[76,144],"in":[77],"pharmaceutical":[78,167],"formulations.":[79],"Various":[80],"analytical":[81,113,137,148,160],"techniques,":[82],"including":[83],"UV-visible":[84],"spectroscopy,":[85],"HPLC,":[86],"RP-HPLC,":[87],"HPTLC,":[88],"LC-MS,":[89],"other":[91],"chromatographic":[92],"methods,":[93],"can":[94],"be":[95],"employed":[96],"its":[98],"estimation.":[99],"Method":[100],"validation":[101,116],"performed":[103],"ensure":[105],"reliability":[107],"consistency":[109],"developed":[112],"procedures.":[114],"Important":[115],"parameters":[117],"include":[118],"accuracy,":[119],"precision,":[120],"specificity,":[121],"linearity,":[122],"robustness,":[123],"range,":[124],"limit":[125,129],"detection,":[127],"quantification.":[131],"This":[132],"review":[133,153],"focuses":[134],"on":[135],"different":[136],"methods":[138,161],"reported":[139],"estimation":[142],"compares":[146],"their":[147],"performance":[149],"applicability.":[151],"The":[152],"highlights":[155],"importance":[157],"validated":[159],"routine":[163],"analysis":[168],"tirzepatide.":[170]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}